MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowlby, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowlby, M. R.

Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons

MR Bowlby

Department of Neurobiology, Harvard Medical School, Boston, Massachusetts 02115.

Many actions of the classical gonadal and adrenal steroid hormones are at the level of transcriptional regulation. Recent studies have shown, however, that endogenous brain metabolites of steroids exert important nongenomic modulatory effects on neuronal mechanisms. Potentiation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor by the neurosteroid pregnenolone sulfate (PS) was studied using cultured hippocampal neurons and patch-clamp techniques. The magnitude of NMDA- activated whole-cell currents was approximately doubled in the presence of 100 microM PS. The dose-response curve of PS action showed significant potentiation above 250 nM and a half-maximal effect at approximately 29 microM. Maximum potentiation was reached within 25 sec, and the potentiation was completely reversed with 60 sec of washout. The enhancement of the NMDA current is probably not due to activation of a new ionic conductance, because the reversal potential of the I-V curve did not shift in the presence of PS. Potentiation is specific for the NMDA subtype of glutamate receptor; non-NMDA currents showed only a slight inhibition (approximately 6%) in the presence of 50 microM PS. Potentiation of the NMDA current by PS occurred in the presence of saturating concentrations of NMDA and glycine, indicating that at saturating concentrations of the coagonists PS does not change the affinity between the coagonists and the NMDA receptor. The dose- response relations for NMDA and glycine were shifted slightly to the left, and the percent potentiation was significantly higher for lower concentrations of coagonists, suggesting that at low concentrations of the coagonists PS may slightly increase their affinity for the NMDA receptor. The fractional open time (nPo) of single NMDA-activated channels was potentiated by PS in patch-clamp recordings using both the outside-out and cell-attached configurations. The potentiation of nPo resulted from increases in the frequency of opening and in the mean channel open time. No effect was seen on single-channel conductances.

Volume 43, Issue 5, pp. 813-819, 05/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Petrovic, M. Sedlacek, M. Horak, H. Chodounska, and L. Vyklicky Jr
20-Oxo-5{beta}-Pregnan-3{alpha}-yl Sulfate Is a Use-Dependent NMDA Receptor Inhibitor
J. Neurosci., September 14, 2005; 25(37): 8439 - 8450.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Horak, K. Vlcek, M. Petrovic, H. Chodounska, and L. Vyklicky Jr
Molecular Mechanism of Pregnenolone Sulfate Action at NR1/NR2B Receptors
J. Neurosci., November 17, 2004; 24(46): 10318 - 10325.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-K. Jang, D. F. Mierke, S. J. Russek, and D. H. Farb
A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity
PNAS, May 25, 2004; 101(21): 8198 - 8203.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING
Nongenomic Steroid Action: Controversies, Questions, and Answers
Physiol Rev, July 1, 2003; 83(3): 965 - 1016.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Meyer, M. Carta, L. D. Partridge, D. F. Covey, and C. F. Valenzuela
Neurosteroids Enhance Spontaneous Glutamate Release in Hippocampal Neurons. POSSIBLE ROLE OF METABOTROPIC sigma 1-LIKE RECEPTORS
J. Biol. Chem., August 2, 2002; 277(32): 28725 - 28732.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Urani, F. J. Roman, V.-L. Phan, T.-P. Su, and T. Maurice
The Antidepressant-Like Effect Induced by sigma 1-Receptor Agonists and Neuroactive Steroids in Mice Submitted to the Forced Swimming Test
J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1269 - 1279.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Kimoto, T. Tsurugizawa, Y. Ohta, J.'y. Makino, H.-o. Tamura, Y. Hojo, N. Takata, and S. Kawato
Neurosteroid Synthesis by Cytochrome P450-Containing Systems Localized in the Rat Brain Hippocampal Neurons: N-Methyl-D-Aspartate and Calcium-Dependent Synthesis
Endocrinology, August 1, 2001; 142(8): 3578 - 3589.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. R. Engel, R. H. Purdy, and K. A. Grant
Characterization of Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 489 - 495.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling
Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects
Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. E. Weaver, M. B. Land, R. H. Purdy, K. G. Richards, T. T. Gibbs, and D. H. Farb
Geometry and Charge Determine Pharmacological Effects of Steroids on N-Methyl-D-aspartate Receptor-Induced Ca2+ Accumulation and Cell Death
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 747 - 754.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Park-Chung, F.-S. Wu, R. H. Purdy, A. A. Malayev, T. T. Gibbs, and D. H. Farb
Distinct Sites for Inverse Modulation of N-Methyl-D-Aspartate Receptors by Sulfated Steroids
Mol. Pharmacol., December 1, 1997; 52(6): 1113 - 1123.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. A. Rose, G. Stapleton, K. Dott, M. P. Kieny, R. Best, M. Schwarz, D. W. Russell, I. Bjorkhem, J. Seckl, and R. Lathe
Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha -hydroxy dehydroepiandrosterone and 7alpha -hydroxy pregnenolone
PNAS, May 13, 1997; 94(10): 4925 - 4930.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Sun, S. G. Rane, P. G. Gunasekar, J. L. Borowitz, and G. E. Isom
Modulation of the NMDA Receptor by Cyanide: Enhancement of Receptor-Mediated Responses
J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1341 - 1348.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. Stapleton, M. Steel, M. Richardson, J. O. Mason, K. A. Rose, R. G. M. Morris, and R. Lathe
A Novel Cytochrome P450 Expressed Primarily in Brain
J. Biol. Chem., December 15, 1995; 270(50): 29739 - 29745.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics